MedTrace Logo

Symptom Spectrum and Risk Factors for Fever in Pediatric and Adult Patients With Omicron Infection

NCT06463821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2591

Last updated 2024-06-18

No results posted yet for this study

Summary

The omicron variant of coronavirus disease 2019 (COVID-19) has caused a global epidemic in 2022. The aim was to investigate the symptom spectrum and risk factors for fever in pediatric and adult patients with omicron infection. From April 8, 2022 to May 17, 2022, this prospective observational study included patients who attended the child-parent sections of the Fangcang shelter hospitals with laboratory-confirmed COVID-19. Patient data were collected from questionnaires. The risk factors for prolonged fever and high fever were identified by univariate and multivariate analyses.

Conditions

  • Symptom Spectrum and Risk Factors for Fever

Interventions

OTHER

observational questionnaires

Patient data were collected from questionnaires.

Sponsors & Collaborators

  • Shanghai Children's Medical Center

    lead OTHER

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-08
Primary Completion
2022-05-17
Completion
2022-05-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06463821 on ClinicalTrials.gov